Medistep Healthcare IPO: All You Need to Know Before Investing

Medistep Healthcare Limited is launching an Initial Public Offering (IPO) through a fixed price issue of 37.44 lakh shares. This IPO is entirely a fresh issue, meaning that all 37.44 lakh shares being offered are newly issued by the company, and no existing shares are being sold by current shareholders.

IPO Dates and Allotment Details

The exact dates for the Medistep Healthcare IPO have not yet been announced. However, the allotment of shares is expected to be finalized once the subscription period concludes. Investors will need to wait for further updates from the company regarding the final dates and other related developments.

Price Band Information

The price band for the Medistep Healthcare IPO is yet to be disclosed. The company is expected to announce the final price range closer to the opening date of the issue.

Key Parties Involved

• Fast Track Finsec Pvt Ltd has been appointed as the book-running lead manager (BRLM) for the IPO. The BRLM is responsible for managing and overseeing the overall IPO process, including pricing, marketing, and distribution of shares.

• Cameo Corporate Services Limited will act as the registrar for the IPO, handling the share allocation process, refunds, and other investor-related services.

Investors seeking more detailed information about the Medistep Healthcare IPO, including the company’s financial performance, risk factors, and business strategy, can refer to the Draft Red Herring Prospectus (DRHP). The DRHP provides a comprehensive overview of the offering and the company’s plans for utilizing the funds raised through the IPO.

Further announcements regarding the IPO dates, price band, and other key details are expected soon.

Promoters and Management

Medistep Healthcare is backed by experienced promoters with a strong background in the healthcare industry. The company’s promoters are:

• Girdhari Lal Prajapat

• Dabhi Vipul Gobarbhai

• Prajapati Hetalben Girdharilal

Promoter Shareholding

• Pre-Issue Holding: 93.62%

• Post-Issue Holding: 68.96%

Management and Operations

As of December 28, 2024, the company has nine employees on its payroll. Medistep relies on daily-paid laborers to meet production demands, and none of the workers are currently under contract.

Competitive Strengths

Medistep Healthcare believes its business model and operational strategy provide several competitive advantages:

• Experienced Management Team: The company benefits from the deep industry knowledge and experience of its promoters and senior management.

• Economies of Scale: Efficient resource utilization and cost-saving measures contribute to the company’s profitability and ability to offer competitive pricing.

• Diverse Product Portfolio: Medistep’s wide range of products, including pharmaceutical, nutraceutical, and personal care items, allows it to serve multiple market segments.

IPO Management

• Book-Running Lead Manager: Fast Track Finsec Pvt Ltd has been appointed to oversee the IPO process, including pricing, marketing, and distribution.

• Registrar: Cameo Corporate Services Limited will handle the share allocation process, refunds, and other investor-related services.

Regulatory Status

Medistep Healthcare filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on March 30, 2024. The DRHP contains detailed information about the company’s financials, business model, and risk factors.

Medistep Healthcare Limited aims to use the funds raised from the IPO to strengthen its market presence, expand production capacity, and enhance working capital. Further details about the price band and subscription dates are expected to be announced soon. Investors are encouraged to review the DRHP for a comprehensive understanding of the company and its offering.